| Bio-Rad Laboratories is a manufacturer and distributor of its own life science research and clinical diagnostics products. Co.'s business is organized into two reportable segments: Life Science, which develops, manufactures, sells and services reagents, apparatus and instruments used for biological research; and Clinical Diagnostics, which develops, manufactures, sells and services automated test systems, informatics systems, test kits and quality controls for the healthcare market. Co. sells its products and services to a client base comprised of scientific research, healthcare, education and government customers. We show 47 historical shares outstanding datapoints in our BIO shares outstanding history coverage, used to compute BIO market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BIO market cap history over the course of time is important for investors
interested in comparing BIO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BIO versus a peer is one thing; comparing
BIO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BIO can fluctuate over the course of history.
With this page we aim to empower investors researching BIO by allowing them to research the BIO market cap history.